Industry Reports

  • The world bank group:World Development Report 2022

    2022-02-15

    World Development Report 2022: Finance for an Equitable Recovery examines the central role of finance in the economic recovery from COVID-19. Based on an in-depth look at the consequences of the crisis most likely to affect low- and middle-income economies, it advocates a set of policies and measures to mitigate the interconnected economic risks stemming from the pandemic—risks that may become more acute as stimulus measures are withdrawn at both the domestic and global levels. Those policies include the efficient and transparent management of nonperforming loans to mitigate threats to financial stability, insolvency reforms to allow for the orderly reduction of unsustainable debts, innovations in risk management and lending models to ensure continued access to credit for households and businesses, and improvements in sovereign debt management to preserve the ability of governments to support an equitable recovery....

    >>

  • Global Wellness Institute:The Global Wellness Economy-Looking Beyond COVID

    2021-12-28

    The Global Wellness Institute (GWI) defines wellness as the active pursuit of activities, choices,and lifestyles that lead to a state of holistic health. There are two important aspects to this definition. First, wellness is not a passive or static state, but rather an “active pursuit” that is associated with intentions, choices, and actions. Second, wellness is linked to holistic health – that is, it extends beyond physical health and incorporates many different dimensions, including physical, mental, emotional, spiritual, social, and environmental dimensions....

    >>

  • Deloitte:Intelligent drug launch and commercial Optimising value through AI

    2021-05-22

    This is the fifth report in our Intelligent biopharma series, which explores the current and future potential of artificial intelligence (AI) across the biopharma value chain.1 This report focuses on how companies can use AI to improve drug launches and their commercial models....

    >>

  • McKinsey & Company:Leap to the future of healthcare: Reinvent through business building

    2021-05-22

    Reinventing business models and building new sources of revenue have never been more important for the healthcare industry, especially as it seeks to improve lives and livelihoods. As we note in our article, “The great acceleration in healthcare: Six trends to heed,” business model reinvention is increasingly becoming essential to deliver greater value to stakeholders in the areas of quality, affordability, access, experience, and equity....

    >>

  • The Lancet: Social innovation in global health: sparking location action

    2020-05-02

    Health innovation is often developed in response to local challenges, fueled from frontline health workers by unique needs and opportunities. Yet the power to scale up innovation is often vested in high-level authorities that have limited understanding of local contexts. How can innovation in global health be sparked? A growing social innovation in health movement shows that innovation is more effective when it emerges bottom-up from low-income and middle-income countries....

    >>

  • Mckinsey: Understanding the impact of unmet social needs on consumer health and healthcare

    2020-02-04

    Healthcare industry stakeholders increasingly recognize that in order to deliver improved health outcomes, it is necessary to address the social factors that influence consumer health....

    >>

  • McKinsey: Seven healthcare industry trends to watch in 2020

    2020-02-04

    Healthcare is an essential, dynamic, and opportunity-rich industry. The demand for innovation to drive simultaneous improvement in health outcomes, affordability, quality, and access will continue to be high....

    >>

  • Deloitte: Global consumer trends in health care

    2020-01-04

    What are the consumer behaviors that are impacting the global health care ecosystem? From North America to Asia to Europe, digital tools and other technologies are helping consumers take more control of their health, according to results of Deloitte’s recent global health care consumer survey. As a part of this research, we surveyed over 26,500 consumers in eight countries - Australia, Canada, Denmark, Germany, the Netherlands, Singapore, the United Kingdom, and the United States. To further explore the findings from the survey, each of these countries has developed a local assessment of the results. Explore this blog series that showcases these country perspectives....

    >>

  • Forbes: Top 8 Predictions That Will Disrupt Healthcare in 2020

    2019-12-04

    Every year, our team of futurists, analysts, and consultants at Frost & Sullivan's Transformational Healthcare Group comes together to brainstorm and predict the themes, technologies, and global forces that will define the next 12 to 18 months for the healthcare industry. We also retrospect how we did each year, and each year we are becoming more accurate in the predictions we make....

    >>

  • Oxford Economics: ACCENTURE 2019 DIGITAL HEALTH CONSUMER SURVEY

    2019-08-04

    The future of healthcare delivery is approaching quickly. Oxford Economics worked with Accenture to field a survey of nearly 8,000 consumers across seven countries about their experiences with both traditional healthcare and alternative methods like walk-in clinics, virtual care, and on-demand services....

    >>

  • Promoting an overdue digital transformation in healthcare

    2019-06-15

    For all the ways that technology is transforming the way people shop, bank, and travel, it has yet to make major inroads into how they receive healthcare. The adoption of digitally enabled tools for diagnosis, treatment, and management, for example, has been modest. Electronic medical records are still not a part of routine care. According to the Electronic Medical Record Adoption model, adoption ranges from just 3 percent in Europe to 35 percent in the United States....

    >>

  • Accenture: 2019 Digital Health Trends Report

    2019-06-07

    To better understand the huge opportunities that digital health solutions present for California, Accenture and the California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, have conducted the state’s fi rst-ever study on digital health amongst life sciences companies. Executives from 184 biopharmaceutical, medical device and technology companies, with revenues exceeding $10 million, participated in our industry-wide survey. Additionally, we conducted 25 interviews with C-level life science thought leaders to get an inside look at the innovation going on in the digital health space....

    >>

  • Accenture: Digital Health Tech Vision 2019

    2019-06-04

    It has become part of everything we do as people, as businesses and society. However, its impact on the expectations of individual people is changing. People are increasingly expecting healthcare on their own terms, and they expect digital to be the enabler....

    >>

  • Mckinsey: The era of exponential improvement in healthcare?

    2019-05-20

    Healthcare advances have delivered great benefits to society, bringing material improvements in average life spans and quality of life. Yet these improvements have come at a cost—an ever-expanding portion of the US GDP is being consumed by healthcare expenses....

    >>

  • Global Healthcare Private Equity and Corporate M&A Report 2020

    2019-05-04

    The disclosed value of healthcare corporate M&A rose by 25% in 2019, to a new high of $541 billion. Two megamergers—namely, Bristol-Myers Squib acquired Celgene, and AbbVie bought Allergan—totaled $182 billion. We expect brisk deal activity to continue in the near future as public healthcare companies use acquisitions to grow revenue, which public markets continue to reward differentially relative to profit margin expansion. New Bain & Company analysis of S&P Capital IQ data shows that revenue growth accounts for 62% of total shareholder returns over the past five years, a far more important factor than profit margin expansion, which accounts for only 9%....

    >>

12